When staff are overextended and patients face delays or abandon care, the issue is no longer a narrow administrative burden. It becomes a business, financial, and access challenge that demands a different operating model. The post Prior Authorization Is Draining Revenue: Why Automation Has Become a Strategic Imperative appeared first on MedCity News.

The question is not whether the technology is impressive. The question is whether it shows up at the right time, with the right information, inside the workflow where the decision is being made. Anything else is just another report. The post How AI Inside Clinical Workflows Is Unlocking Patient Throughput appeared first on MedCity News.

As patients increasingly bring AI chatbot advice into exam rooms, where does liability land when that advice goes wrong? Health law attorney Meghan O’Connor said the answer still isn’t clear, but silence is the riskiest response for providers. The post What Happens When Patients Trust AI Over Their Doctor? appeared first on MedCity News.

Crystalys’s dotinurad is currently in pivotal testing for gout, a prevalent inflammatory disorder with few treatment options. The drug has the same mechanism of action as a molecule that Sobi added to its pipeline through a $950 million acquisition. The post Crystalys Therapeutics Tacks On $130M for Pivotal Tests of Gout Drug appeared first on MedCity News.

Candid’s Series D round was led by Sixth Street Growth, with participation from Oak HC/FT, 8VC and Y Combinator. The post Candid Health Snags $120M for AI RCM Platform appeared first on MedCity News.

VBC aligns reimbursements to outcomes, emphasizing the quality and effectiveness, not quantity, of healthcare activities. But the same cost constraints driving interest in VBC can also turn it into a liability. The post Why Value-Based Care Only Works If You’ve Tamed Costs appeared first on MedCity News.

A core principle of trauma-informed care is understanding that past and ongoing exposure to stress and trauma can directly shape health outcomes. But by remaining blind to these histories, the medical community severely limits its ability to address the very drivers of the diseases it is trying to cure. The post Medicine Understands Trauma’s Impact, But Rarely Asks About It appeared first on MedCity News.

Drug spending continues to grow, but that doesn’t mean that everyone is getting the medicines that they need. A panel at MedCity News’ Bullseye event discussed the evolution of the prescription drug marketplace. The post A Prescription for Drug Costs: Inject Transparency and Improve Accessibility appeared first on MedCity News.

Health tech investors say the founders who win them over aren’t the ones with all the answers, but the ones who know exactly what they don’t know — and build a team to cover the gap. The post What Health Tech Investors Love in Founders — and What They Can’t Stand appeared first on MedCity News.

Priority Health partnered with Color Health and Grail to offer self-funded employers virtual cancer navigation, support and multi-cancer early detection beginning in 2027. The post Priority Health Launches 2 Cancer Support Solutions with Color Health, Grail appeared first on MedCity News.

We’re about to enter a world beyond just talking to a chat tool about your health. AI tools are on the precipice of being able to take action on their advice.   The post AI Will Reshape the Patient Experience appeared first on MedCity News.

The question is no longer whether healthcare innovation is accelerating. The question is where investors gain access to generate the strongest returns. The post Healthcare’s Next Source of Alpha Is Moving Upstream appeared first on MedCity News.

Scribe Therapeutics’ IPO will support a pipeline led by a genetic medicine that represses expression of its target gene without making permanent changes. Common chronic cardiometabolic conditions are Scribe’s initial focus as the biotech works to bring genetic medicines beyond rare diseases. The post CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO appeared first on MedCity News.

Unlike past healthcare tech waves sold on cost savings, AI is proving it can generate new revenue — with returns as high as 100x, according to a panel of investors at MedCity News’ Bullseye event. The post Healthcare Investors Are Rewriting the ROI Playbook from Cost-Cutting to Cash Flow appeared first on MedCity News.